Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis

Fig. 1

Complement activation markers in systemic sclerosis and other autoimmune diseases. Graphs show mean and standard deviation of C4d (left panel), C3bBbP (middle panel) and soluble terminal complement complex (TCC) (right panel) concentrations. Value obtained for each patient (depicted with single points) is an average of two independent experiments. Statistical analysis was performed by Kruskal-Wallis test with Dunn’s multiple comparisons post-test, and statistical significance was set at *p < 0.05 and ***p < 0.001.Abbreviation: CAU Complement activation units

Back to article page